Skip to main content
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc. — Investor Relations & Filings

Ticker · PYXS ISIN · US7473241013 US Manufacturing
Open in API
Filings indexed 308 across all filing types
Latest filing 2021-10-08 Director's Dealing
Country US United States of America
Listing US PYXS

About Pyxis Oncology, Inc.

https://pyxisoncology.com/

Pyxis Oncology, Inc. is a clinical-stage company focused on developing next-generation therapeutics for difficult-to-treat cancers. The company's differentiated portfolio of clinical assets is centered on two primary modalities: antibody-drug conjugates (ADCs) and immuno-oncology (IO). Its ADC technology platform is designed to deliver potent cancer-killing agents directly to tumor cells for enhanced safety and efficacy. The immuno-oncology programs utilize monoclonal antibodies (mAbs) to mobilize the body's immune system to attack cancer cells by blocking tumor defense mechanisms and overcoming immune suppression. Pyxis Oncology is advancing its product candidates as both monotherapies and in combination with other therapies to improve outcomes for patients with solid tumors.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2021-10-08 English
FORM 3
Director's Dealing
2021-10-08 English
Regulatory Filings 2021
Regulatory Filings
2021-10-07 English
FORM 3
Director's Dealing
2021-10-07 English
S-1/A
Regulatory Filings Classification · 95% confidence The document is a Form S-1/A Registration Statement Amendment No. 3 filed with the SEC by Pyxis Oncology, Inc. It is a detailed registration statement for an initial public offering (IPO) of common stock. The text includes the SEC header, registration number, company details, offering details, underwriting information, and a prospectus summary. This type of filing is a regulatory filing related to securities registration and offering, not an annual report, earnings release, or other financial report. It is not a report publication announcement but the actual registration statement document. The S-1/A is a standard SEC filing for IPO registration and amendments thereto, which falls under the category of Regulatory Filings (RNS) in the given classification scheme because it is a general regulatory announcement and compliance document that does not fit into other specific categories like Annual Report or Earnings Release.
2021-10-07 English
Regulatory Filings 2021
Regulatory Filings
2021-10-06 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.